07
January
0
Comments
Cooley Guides Cancer-Focused Biotech’s $115M IPO Filing
in Legal News
Law360 (January 7, 2019, 7:40 PM EST) — Early-stage biotechnology firm Poseida Therapeutics Inc., which is developing therapies for multiple myeloma and prostate cancer, said in a late Friday filing with the U.S. Securities and Exchange Commission that it…
